Latest return on equity
Black Diamond Therapeutics Return on equity
Direct answer
Black Diamond Therapeutics's return on equity is -37.21%.
The verified market snapshot reports -37.21%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Black Diamond Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -37.21%
Explore related company data
View Black Diamond Therapeutics's market capitalizationView Black Diamond Therapeutics's price-to-book ratioView Black Diamond Therapeutics's dividend yieldView Black Diamond Therapeutics's 52-week price rangeView Black Diamond Therapeutics's profit marginView Black Diamond Therapeutics's debt-to-equity ratioView all Black Diamond Therapeutics key metricsReturn to Black Diamond Therapeutics profile